HPTN 059
Phase II Expanded Safety and Acceptability Study of the
Vaginal Microbicide 1% Tenofovir Gel
-
Study Design
-
Eligibility Criteria
-
Administrative, Behavioral, and Regulatory Procedures
-
Clinical Procedures
-
Laboratory Procedures
-
Study Product Considerations
-
Data Collection and Management
-
Human Subjects Considerations
-
Study Monitoring Considerations
-
Other
|